发明名称 Targeted therapeutic nanoparticles
摘要 Disclosure of methods and compositions related to chemical conjugations to nanoparticles of polysaccharides cross-linked to poloxamers as well as nano-sized colloids comprised of polysaccharides and poloxamers. The nanoparticles may be produced by various methods including inverse miniemulsion polymerization processes which create nanogels of desired size, shape, and stability for controlled therapeutic drug delivery, imaging, and theragnostic applications.
申请公布号 US9161962(B2) 申请公布日期 2015.10.20
申请号 US201313943074 申请日期 2013.07.16
申请人 nanoDERM Sciences, Inc. 发明人 Yeoman Roy R.;Winchurch Richard A.
分类号 A61K47/48;A61K39/44;A61K38/12;A61K31/713;A61K9/06;A61K47/36;B82Y5/00;C08B37/02;C08J3/075;C08L5/02;C08L63/00 主分类号 A61K47/48
代理机构 Bernard G. Pike, Pike IP Law, PLLC 代理人 Bernard G. Pike, Pike IP Law, PLLC
主权项 1. A nanoparticle targeting molecule, comprising: a polymeric network comprising a plurality of first block copolymeric segments are derived from block copolymers comprising at least one block of ethylene oxide monomers and at least one block of propylene oxide monomers and a plurality of second polymeric segments derived from dextran; a polymyxin B targeting agent conjugated to at least a portion of the second polymeric segments of the polymeric network; and an antibacterial encapsulated in the polymeric network.
地址 Derwood MD US